Trial Profile
A Phase I Study of Preoperative Chemoradiation With Oxaliplatin, 5-Fluorouracil, Erlotinib and Radiation Followed by Resection and Consolidative Erlotinib for Patients With Locally Advanced Cancer of the Esophagus and Gastroesophageal Junction
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Erlotinib; Fluorouracil
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 17 Apr 2017 Status changed from active, no longer recruiting to completed.
- 17 Apr 2017 Status changed from active, no longer recruiting to completed.
- 21 Mar 2012 Trial phase changed from I to I/II as reported by ClinicalTrials.gov. (NCT01561014)